🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Benchmark increases Axcelis Technologies shares target, highlights future growth

EditorEmilio Ghigini
Published 07/15/2024, 07:13 AM
ACLS
-

On Monday, Benchmark, a financial advisory firm, raised its price target on Axcelis Technologies (NASDAQ:ACLS) shares to $180 from the previous $170, while maintaining a "Buy" rating on the stock. The adjustment follows Axcelis Technologies' Investor Day event, which took place during the Semicon meetings in San Francisco.

At the Investor Day, Axcelis outlined its future growth opportunities and presented a model projecting the company's performance up to the year 2027. The company also preannounced that it had achieved results for the June quarter that exceeded expectations and provided guidance indicating higher results for the second half of 2024.

The raised price target reflects the company's positive preannouncement and the expectation of continued strong performance in the coming months. This announcement is likely to be of interest to investors and market watchers, as it signals confidence in Axcelis Technologies' growth trajectory and financial health.

Axcelis Technologies is known for its contributions to the semiconductor industry, providing equipment, services, and process expertise to help chip manufacturers produce advanced semiconductor devices. The company's positive outlook and the upgraded target from Benchmark come at a time when the semiconductor industry continues to evolve rapidly.

Investors and stakeholders in the semiconductor sector may view this updated price target as a positive sign for Axcelis Technologies' stock performance and overall market position. The company's focus on future growth and the optimistic guidance for the latter half of 2024 are key factors contributing to the positive assessment by Benchmark.

In other recent news, Axcelis Technologies has seen numerous adjustments to its stock price target by various analyst firms, following the company's optimistic forecast for substantial growth.

DA Davidson raised the price target for Axcelis shares to $175, citing significant growth projections including revenues of $1.6 billion and earnings of $11.50 per share by 2027. Similarly, Craig-Hallum increased the price target for Axcelis to $174, while B.Riley lifted the price target to $190, and both firms maintained a Buy rating.

These adjustments follow robust Q1 2024 results for Axcelis, which reported revenues of $252.4 million and earnings per diluted share at $1.57. The company's promising financial outlook is based on expectations of industry upturn, geographic expansion, and strong product momentum.

In addition to financial developments, Axcelis has expanded its presence in Japan by opening new service offices in Chitose, Hokkaido, and Kumamoto, Kyushu. This move is part of Axcelis's strategic efforts to enhance its market share and provide localized support for its Purion ion implant equipment.

While DA Davidson, Craig-Hallum, and B.Riley have all shown confidence in Axcelis's future performance, it's important to note that these are projections and actual results may vary. As always, investors are encouraged to stay tuned for future updates from Axcelis Technologies.

InvestingPro Insights

Following Benchmark's optimistic outlook on Axcelis Technologies, a peek into the real-time data from InvestingPro provides additional context for investors considering this stock. With a market capitalization of $4.84 billion, Axcelis shows a healthy financial stance. Notably, the company is currently trading at a P/E ratio of 19.78, which is attractive when paired with its near-term earnings growth prospects. This aligns with one of the InvestingPro Tips, highlighting that Axcelis is trading at a low P/E ratio relative to its earnings growth.

The company's revenue growth over the last twelve months has been impressive at 16.34%, signaling a robust expansion in its business operations. Furthermore, the strong return of 42.57% over the last three months and the 30.34% increase over the past six months could be indicative of the market's positive reception to Axcelis's strategies and performance. These data points are crucial for investors, as they reflect both the company's recent momentum and potential for sustained growth.

InvestingPro also notes that Axcelis holds more cash than debt on its balance sheet, which is a reassuring sign of financial stability. Additionally, Axcelis is expected to remain profitable this year, as per analyst predictions. For those seeking further insights, InvestingPro offers additional tips on Axcelis Technologies. By using the coupon code PRONEWS24, investors can get up to 10% off a yearly Pro and a yearly or biyearly Pro+ subscription to access these valuable tips. In total, there are 12 more InvestingPro Tips available that could aid in making a well-informed investment decision.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.